logo
iShares S&P / TSX 60 Index ETF Stock (TSE:XIU) Makes Small Gains, Along With Wholesale Prices

iShares S&P / TSX 60 Index ETF Stock (TSE:XIU) Makes Small Gains, Along With Wholesale Prices

Prices are going up in Canada again, or so says the latest word from Statistics Canada. Thankfully, though, the boost will be comparatively small, and some households may never be able to tell the difference between normal high prices and these slightly higher wholesale prices. The iShares S&P / TSX 60 Index fund (TSE:XIU) counted good enough as good enough, and posted a fractional gain in Monday morning's trading.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Wholesale prices—except for oilseed, petroleum, petroleum products, and assorted hydrocarbons—gained 0.1% in May. That brought the overall basket of materials involved to $84.2 billion. The gains were hardly universal; the same study noted that the personal goods and household goods sectors saw increases of 3.5%, which meant sales were on the rise. That gave some explanation for the small uptick in prices.
Some parts gained more than others; the motor vehicle sector, for example, gained just 2.2%. Some sectors even managed to lose ground, though these were a bit less seen in typical Canadian household shopping. For instance, forestry, mining and industrial machinery, equipment and supplies dropped 3.9%. Farm, lawn and garden machinery and equipment, meanwhile, plummeted down 17.1%.
A Quantum Computing Revolution
But despite this unexpected shift in wholesale prices, Canada also delivered a noteworthy advance in quantum computing. SuperQ recently opened the first-ever quantum computing Super Hub location in Lethbridge, Alberta. Opened at the Tecconnect Innovation Centre therein, the Super Hub gives clients access to its Super platform. Super is similar to ChatGPT in nature, reports note, though also offers quantum computing services as well as '…high-performance computing capabilities.'
SuperQ picked Lethbridge for the honor thanks to what SuperQ called '…a proven track record of pioneering AI, blockchain and IoT programs catering to industry needs.' The fact that Lethbridge was also '…a convergence point of Canada's Premiere Food Corridor and Western Gateway that comprise major manufacturing and supply chain activities…' did not hurt either.
Is the iShares S&P / TSX 60 Index ETF a Good Buy Right Now?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on TSE:XIU shares based on 52 Buys and nine Holds assigned in the past three months, as indicated by the graphic below. After a 18.27% rally in its share price over the past year, the average TSE:XIU price target of $44.18 per share implies 8.26% upside potential.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asian Stocks Estimated To Be 12.7% To 26.2% Below Intrinsic Value
Asian Stocks Estimated To Be 12.7% To 26.2% Below Intrinsic Value

Yahoo

time10 minutes ago

  • Yahoo

Asian Stocks Estimated To Be 12.7% To 26.2% Below Intrinsic Value

As global markets respond to favorable trade deal news, Asian equities have shown resilience amid ongoing tariff discussions and economic uncertainties. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors looking to capitalize on market inefficiencies. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) Shin Maint HoldingsLtd (TSE:6086) ¥1174.00 ¥2321.82 49.4% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥23.34 CN¥46.18 49.5% Range Intelligent Computing Technology Group (SZSE:300442) CN¥51.15 CN¥101.32 49.5% Polaris Holdings (TSE:3010) ¥220.00 ¥433.40 49.2% Nan Ya Printed Circuit Board (TWSE:8046) NT$177.00 NT$350.10 49.4% LigaChem Biosciences (KOSDAQ:A141080) ₩139000.00 ₩277490.02 49.9% Hibino (TSE:2469) ¥2345.00 ¥4664.61 49.7% Heartland Group Holdings (NZSE:HGH) NZ$0.82 NZ$1.62 49.4% Forum Engineering (TSE:7088) ¥1206.00 ¥2405.10 49.9% Andes Technology (TWSE:6533) NT$274.50 NT$542.92 49.4% Click here to see the full list of 265 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Dongsung FineTec Overview: Dongsung FineTec Co., Ltd. is a South Korean company that manufactures and sells cryogenic insulation products, with a market cap of approximately ₩811.48 billion. Operations: The company's revenue segments include the Gas Business, generating approximately ₩23.03 billion, and Cooling Material, contributing around ₩609.47 billion. Estimated Discount To Fair Value: 26.2% Dongsung FineTec is trading at ₩27,950, significantly undervalued compared to its estimated fair value of ₩37,869.08. Its earnings are projected to grow at 22.6% annually, outpacing the Korean market's growth rate and reflecting robust financial health despite an unstable dividend track record. Recent quarterly results showed net income of KRW 9 billion, up from KRW 8.69 billion a year earlier, reinforcing its strong cash flow position in the Asian market. Our growth report here indicates Dongsung FineTec may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Dongsung FineTec's balance sheet health report. Nanjing Vazyme Biotech Overview: Nanjing Vazyme Biotech Co., Ltd provides technology solutions in life science, biomedicine, and in vitro diagnostics with a market cap of CN¥10.52 billion. Operations: Nanjing Vazyme Biotech Co., Ltd generates revenue through its technology solutions in life science, biomedicine, and in vitro diagnostics. Estimated Discount To Fair Value: 17.1% Nanjing Vazyme Biotech is trading at CN¥26.44, slightly below its fair value estimate of CN¥31.91, suggesting it may be undervalued based on cash flows. The company is expected to become profitable within three years, with earnings projected to grow 78.27% annually—surpassing market averages despite a low forecasted return on equity of 5.6%. A recent share buyback plan worth CN¥10 million aims to enhance shareholder value through potential equity incentives or employee stock ownership plans. Our expertly prepared growth report on Nanjing Vazyme Biotech implies its future financial outlook may be stronger than recent results. Delve into the full analysis health report here for a deeper understanding of Nanjing Vazyme Biotech. Zhejiang Yinlun MachineryLtd Overview: Zhejiang Yinlun Machinery Co., Ltd. focuses on the research, development, manufacturing, and sale of thermal management and exhaust gas post-treatment products, with a market cap of CN¥24.97 billion. Operations: The company generates revenue primarily from the sale of thermal management and exhaust gas post-treatment products. Estimated Discount To Fair Value: 12.7% Zhejiang Yinlun Machinery is trading at CN¥30.13, undervalued relative to its fair value estimate of CN¥34.53. Earnings grew 18.9% last year and are projected to rise 25.12% annually, outpacing the Chinese market's growth rate of 23.5%. Despite a lower future return on equity forecast of 16.1%, recent share buybacks totaling CN¥34.96 million may enhance shareholder value through equity incentives or employee stock ownership plans. According our earnings growth report, there's an indication that Zhejiang Yinlun MachineryLtd might be ready to expand. Click here and access our complete balance sheet health report to understand the dynamics of Zhejiang Yinlun MachineryLtd. Make It Happen Reveal the 265 hidden gems among our Undervalued Asian Stocks Based On Cash Flows screener with a single click here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A033500 SHSE:688105 and SZSE:002126. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Intel's (INTC) Execution Crisis Goes from Bad to Worse
Intel's (INTC) Execution Crisis Goes from Bad to Worse

Business Insider

time29 minutes ago

  • Business Insider

Intel's (INTC) Execution Crisis Goes from Bad to Worse

Intel's (INTC) turnaround efforts suffered a major setback last week following its Q2 2025 earnings report. While revenue came in at almost $13 billion—essentially flat year-over-year and slightly above analyst expectations—the company's profitability sharply declined. The news pushed INTC more than 10% lower with a quick bounce clearly off the table. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Intel reported a net loss of $2.9 billion, and even on a non-GAAP basis, it posted a $400 million loss, a significant drop from last year's $100 million profit in the same quarter. In my view, the combination of stagnant revenue and deteriorating margins signals deeper structural issues, leading me to maintain a Bearish stance on INTC stock. Intel's 'Kitchen-Sink' Quarter Intel's significant GAAP loss in Q2 stemmed from nearly $3 billion in charges. These included $1.9 billion in restructuring costs related to corporate downsizing and workforce reductions, $800 million in non-cash impairment and accelerated depreciation tied to underutilized assets, and $200 million in one-time expenses. Notably, the $800 million in asset write-downs was publicly criticized by incoming CEO Lip-Bu Tan as the result of 'unwise and excessive' capital investments. Intel's failure to anticipate these charges in Q1 raises concerns about internal oversight and planning. From my perspective, this appears to be a classic 'kitchen-sink' quarter—where new leadership clears the slate by front-loading bad news to reset expectations moving forward. Intel Slashes Its Workforce In the wake of its disappointing Q2 results, Intel unveiled a sweeping workforce reduction plan, aiming to cut headcount by roughly 15%. A significant portion of these layoffs will target middle management, indicating that organizational bloat and bureaucratic inertia may have hindered efficiency. The company plans to initiate a cultural reset—focused on greater accountability and cross-functional collaboration—starting in September. According to TipRanks data, INTC's operating expenses rose sharply during the last quarter. At the same time, Intel is scaling back its ambitious global fab expansion. Its high-profile, multi-billion-dollar projects in Germany and Poland have been scrapped entirely, while the $28 billion chip facility in Ohio is being delayed to better reflect current market demand. Although these decisions are expected to generate substantial cost savings, they also raise questions about Intel's long-term strategic positioning in a rapidly evolving semiconductor landscape. The AI Race Leaves INTC Lagging These sweeping changes raise a critical question: if Intel's previous multi-year strategy was so deeply flawed that it demanded such a dramatic and public course correction, what assurance does the market have that the new plan is any more viable? The simple answer is: very little. Intel appears to be rapidly losing ground to its competitors. Its Data Center and AI segment grew just 4% year-over-year to $3.9 billion. In stark contrast, NVIDIA (NVDA) recently reported $39.1 billion in quarterly data center revenue —an explosive 73% increase. Even Intel's closest peer, Advanced Micro Devices (AMD), is expected to post $7.41 billion in total revenue, up 27% year-over-year, fueled by strong demand for its MI355X AI GPUs. INTC's High-Stakes Foundry Ultimatum Context matters. Intel's legacy Client Computing Group—largely driven by its PC business—continues to struggle, with revenue declining 3% year-over-year to $7.9 billion amid intensifying competition. Meanwhile, the Intel Foundry segment, once positioned as the cornerstone of its turnaround strategy, delivered just 3% year-over-year growth, with profitability still far on the horizon. More concerning is Intel's decision to pause full-scale development and production of its next-generation 14A process node without first securing a major customer. This move carries serious long-term risk: without a committed partner, billions in manufacturing equipment could remain idle and face future write-downs. To be fair, much of this uncertainty appears priced into the stock. Intel's market cap remains below $100 billion, well behind its peers, and INTC's EV/Sales ratio of 2.4 reflects a 32% discount to the broader IT sector. Still, given the company's stagnating growth and ongoing inability to turn a profit, this discount may be justified. Is INTC a Buy, Sell, or Hold? On Wall Street, INTC sports a Hold consensus rating based on one Buy, 25 Hold, and three Sell ratings in the past three months. INTC's average stock price target of $22.25 implies a 7.6% upside potential over the next 12 months. Last week, Morgan Stanley analyst Joseph Moo re maintained a Hold rating on INTC with a price target of $23. The analyst expressed caution, noting that a primary concern is 'Intel's foundry strategy, particularly the development of the 14A process, which is contingent on securing a major foundry customer. This situation leaves Intel in a precarious position, as it is not fully committed to the foundry business, creating uncertainty about its future direction.' There's Little Value in Waiting for INTC's Turnaround Intel's Q2 results provided explicit confirmation of an execution crisis that has been building for years. The company's abrupt shift toward downsizing—while likely essential for survival—raises concerns about its ability to remain technologically competitive over the long term. The added uncertainty surrounding its 14A node, now tied to a high-stakes, go-it-alone strategy, only deepens skepticism around Intel's turnaround potential and renders the investment case increasingly difficult to justify. However, despite the gloom, INTC does have options and potential exit from its market doldrums. If next-gen products like the Panther Lake CPU can recapture market share and ongoing cost-cutting efforts succeed in restoring margins, Intel could emerge from this restructuring phase leaner and more focused. But from where I sit, without sustained, measurable progress, this remains a story best watched from the sidelines, whilst seeking short positions to profit from the gloom.

‘Meta Stock Headed for $800': Mark Zgutowicz Weighs In Ahead of Earnings
‘Meta Stock Headed for $800': Mark Zgutowicz Weighs In Ahead of Earnings

Business Insider

time29 minutes ago

  • Business Insider

‘Meta Stock Headed for $800': Mark Zgutowicz Weighs In Ahead of Earnings

Meta Platforms (NASDAQ:META) stock has had a solid run since hitting a bottom in April, climbing 44%. Investors have been riding the momentum, but all eyes are now turning to Meta's second-quarter earnings call, scheduled for tomorrow, July 30, after the market closes. And this time, the spotlight won't just be on ad impressions or daily active users – it'll be on something far more ambitious. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. That ambition took center stage in mid-July, when CEO Mark Zuckerberg declared Meta's intention to invest 'hundreds of billions of dollars' into AI infrastructure in pursuit of Artificial Superintelligence. This isn't just about smarter ad targeting or better recommendation engines. We're talking about an all-out arms race to build a future where Meta could rival, or even outpace, the likes of OpenAI and Google DeepMind. To turn that vision into reality, Zuckerberg announced plans to build roughly six gigawatts of data center capacity by 2030. Furthermore, Meta has spent the past month recruiting top-tier AI researchers from OpenAI and DeepMind, while also investing $14 billion in Scale AI and appointing its CEO as Meta's Chief AI Officer. One analyst who's paying close attention is Benchmark's Mark Zgutowicz. While he maintains strong expectations for Meta's Q2 performance and sees promise in the company's evolving monetization strategy through e-commerce and ad pricing, the AI push is where the story really gets interesting. According to Zgutowicz, even though his model already accounts for close to $500 million in capital expenditures through 2030, the real test will be in how well management deploys that capital to generate tangible returns. The analyst also notes that Meta faces stiff competition, pointing to OpenAI's current leadership and Google's entrenched dominance across much of the AI landscape, even before OpenAI's anticipated push into advertising in 2026. As for the upcoming earnings, Zgutowicz expects a 'stable top-line' performance supported by steady e‑commerce trends, continued ad pricing momentum in North America, and higher revenue per advertiser thanks to new Advantage+ attribution tools launched in May. He also projects 2025 capex guidance to remain steady, with operating expenses inching higher to reflect the recent influx of elite AI talent. Looking further ahead, the analyst will be watching for management's tone regarding consensus forecasts that call for 2026 capex and opex growth of 9% and 14%, respectively. With these expectations in mind, Zgutowicz assigns Meta stock with a Buy rating, while raising his price target from $640 to $800. (To watch Zgutowicz's track record, click here) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store